These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21241513)

  • 1. Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18.
    Au GG; Beagley LG; Haley ES; Barry RD; Shafren DR
    Virol J; 2011 Jan; 8():22. PubMed ID: 21241513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21.
    Au GG; Lindberg AM; Barry RD; Shafren DR
    Int J Oncol; 2005 Jun; 26(6):1471-6. PubMed ID: 15870858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21.
    Shafren DR; Au GG; Nguyen T; Newcombe NG; Haley ES; Beagley L; Johansson ES; Hersey P; Barry RD
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):53-60. PubMed ID: 14734451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome.
    Sam M; Selman M; Zhao W; Jung J; Willingham A; Phan U; Starling GC; Gao Q
    J Virol; 2023 May; 97(5):e0030923. PubMed ID: 37070982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent oncolytic activity of human enteroviruses against human prostate cancer.
    Berry LJ; Au GG; Barry RD; Shafren DR
    Prostate; 2008 May; 68(6):577-87. PubMed ID: 18288643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride.
    Skelding KA; Barry RD; Shafren DR
    Invest New Drugs; 2012 Apr; 30(2):568-81. PubMed ID: 21170760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21.
    Müller LME; Holmes M; Michael JL; Scott GB; West EJ; Scott KJ; Parrish C; Hall K; Stäble S; Jennings VA; Cullen M; McConnell S; Langton C; Tidswell EL; Shafren D; Samson A; Harrington KJ; Pandha H; Ralph C; Kelly RJ; Cook G; Melcher AA; Errington-Mais F
    J Immunother Cancer; 2019 Jul; 7(1):164. PubMed ID: 31262361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus: Using a Bladder Tumor Precision-Cut Slice Model System to Assess Viral Efficacy.
    Relph K; Annels N; Smith C; Kostalas M; Pandha H
    Methods Mol Biol; 2020; 2058():249-259. PubMed ID: 31486043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Mesenchymal Stem Cells Loaded with Oncolytic
    Karbalaee R; Mehdizadeh S; Ghaleh HEG; Izadi M; Kondori BJ; Dorostkar R; Hosseini SM
    Curr Cancer Drug Targets; 2024; 24(9):967-974. PubMed ID: 38310465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant melanoma with coxsackievirus A21 (V937): An emerging oncolytic virotherapy.
    Sakunchotpanit G; Patil MK; Venkatesh K; Rohan TZ; Cheng D; Nambudiri VE
    Exp Dermatol; 2024 Sep; 33(9):e15169. PubMed ID: 39207089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
    Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
    J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Talimogene laherparepvec (Imlygic) for unresectable melanoma.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):8-9. PubMed ID: 26761342
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.
    Bramante S; Kaufmann JK; Veckman V; Liikanen I; Nettelbeck DM; Hemminki O; Vassilev L; Cerullo V; Oksanen M; Heiskanen R; Joensuu T; Kanerva A; Pesonen S; Matikainen S; Vähä-Koskela M; Koski A; Hemminki A
    Int J Cancer; 2015 Oct; 137(7):1775-83. PubMed ID: 25821063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Talimogene laherparepvec (T-VEC) as cancer immunotherapy.
    Kohlhapp FJ; Zloza A; Kaufman HL
    Drugs Today (Barc); 2015 Sep; 51(9):549-58. PubMed ID: 26488034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization.
    Ilett EJ; Bárcena M; Errington-Mais F; Griffin S; Harrington KJ; Pandha HS; Coffey M; Selby PJ; Limpens RW; Mommaas M; Hoeben RC; Vile RG; Melcher AA
    Clin Cancer Res; 2011 May; 17(9):2767-76. PubMed ID: 21389099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?
    Rothermel LD; Zager JS
    Expert Opin Biol Ther; 2018 Dec; 18(12):1199-1207. PubMed ID: 30392405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21.
    Skelding KA; Barry RD; Shafren DR
    Breast Cancer Res Treat; 2009 Jan; 113(1):21-30. PubMed ID: 18256929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas.
    Jiang H; Shin DH; Nguyen TT; Fueyo J; Fan X; Henry V; Carrillo CC; Yi Y; Alonso MM; Collier TL; Yuan Y; Lang FF; Gomez-Manzano C
    Clin Cancer Res; 2019 Nov; 25(22):6801-6814. PubMed ID: 31455679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acid.
    Hadac EM; Kelly EJ; Russell SJ
    Mol Ther; 2011 Jun; 19(6):1041-7. PubMed ID: 21505425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.
    Colunga AG; Laing JM; Aurelian L
    Gene Ther; 2010 Mar; 17(3):315-27. PubMed ID: 19798049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.